Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 137
- CBD Market
CBD Companies Accuse Payment Provider Of Withholding Cash Worth Tens Of Thousands Of Pounds
HALF a dozen CBD companies are engaged in a dispute with a payments provider which they have accused of withholding tens of thousands of pounds of their money.
- Pharmaceutical
European Cannabis Stocks Review: Jazz Pharma Scraps US Sativex Trial, & IM Cannabis Pulls Out Of Canada
Jazz Pharmaceuticals Jazz Pharmaceuticals, which has become the world’s largest exporter of medical cannabis products since it bought GW Pharmaceuticals for $7.2bn last year, raised its revenue guidance for the full year this week in its Q3 financial results.
- Adult-Use
Switzerland ‘Could Well Become The Next European Country After Germany To Legalise Recreational Cannabis’
AFTER announcing a new joint venture with Solumedics AG last week, allowing it to import and sell medical cannabis in Switzerland for the first time, we spoke to Astrasana‘s CEO Yves Antoniazzi about his plans for the next year, and why now is the ‘perfect’ time to expand into the cannabis industry.
- Adult-Use
Asia On The ‘Cusp Of Cannabis Revolution’ As New Report Suggests Sales Could Skyrocket Tenfold 2026
ASIA’s historically strict approach to cannabis legislation is ‘on the cusp of revolution’ as a wave of re-liberalisation across the region is set to present significant opportunities for international investment.
- News
Portuguese Contract Manufacturing Company Atann Says Fresh Funding Will Allow It To “Realise Its Mission Statement”
ATANN, Portugal’s first cannabis contract manufacturing company, has successfully been granted its GACP (Good Agricultural and Collection Practice) licence, enabling it to begin supplying cannabis clones to licensed cultivators.
- Adult-Use
European Cannabis Stocks Review: Hellenic Dynamics & Cantourage Both Set To Go Public In Coming Months
Hellenic Dynamics Greek medical cannabis cultivator Hellenic Dynamics is reportedly poised to become the first company of its kind to list on the London Stock Exchange (LSE), nearly 18 months since it first announced its intention to go public.
- Medical
Swiss Joint Venture Initiates First Medical Cannabis Import
ASTRASANA Holding AG is an internationally active company focusing on the cultivation, processing and distribution of cannabis products.
- Adult-Use
New Figures Show That 784 More Private Medical Cannabis Prescriptions Were Made In The UK Last Year Than Previously Thought
AS PLEA’s (Patient Lead Engagement for Access) Medical Cannabis Awareness Week (#MCAW2022) launches in the UK this week, fresh figures suggest growth in the number of privately prescribed, unlicensed medical cannabis items dispensed last year was even higher than previously thought.
- Adult-Use
Flora Growth’s $40m Acquisition Of Franchise Global Health Will See It Ready For German Recreational Market ‘When It’s Ready For Us’
FLORA Growth is set to acquire 100% of German medical cannabis and pharmaceutical operator Franchise Global Health in a major deal estimated to be worth over C$40m.
- Uncategorized
Flora Growth erwirbt für 40 Millionen Dollar Franchise Global Health und ist bereit für den deutschen Freizeitmarkt, “wenn er für uns bereit ist”.
FLORA Growth wird 100 % des deutschen Anbieters von medizinischem Cannabis und Pharmazeutika, Franchise Global Health, in einem großen Deal übernehmen, dessen Wert auf über 40 Millionen C$ geschätzt wird.
- Adult-Use
European Cannabis Stocks Review: SynBiotic Jumps On German Progress, DanCann Pharma Recovers & More From Cannabis Poland
SynBiotic Earlier this week the German Health Minister Karl Lauterbach officially unveiled his plans for the legalisation of adult-use cannabis, a week after some details were leaked to the press.
- Uncategorized
Rückblick auf europäische Cannabis-Aktien: SynBiotic springt auf deutschen Fortschritt, DanCann Pharma erholt sich & mehr von Cannabis Poland
SynBiotic Anfang dieser Woche stellte der deutsche Gesundheitsminister Karl Lauterbach offiziell seine Pläne für die Legalisierung von Cannabis für Erwachsene vor, eine Woche nachdem einige Details an die Presse durchgesickert waren.










